AYTU BIOPHARMA, INC (AYTU)
Data as of , from SEC Form 4 filings.
See up to 3 months of AYTU. The 7-day demo opens the 1M and 3M ranges and puts AYTU on your watchlist.
Start 7-day demoLatest AYTU insider trades
- Joshua R. Disbrow - OfficerGrant or award30,000 sh
- Greg Pyszczymuka - OfficerGrant or award20,000 sh
- Jarrett Disbrow - OfficerGrant or award15,000 sh
Ryan J. Selhorn - OfficerGrant or award25,000 sh- Vivian H. Liu - DirectorGrant or award10,000 sh
- Abhinav Jain - DirectorGrant or award10,000 sh
- Carl Dockery - DirectorGrant or award10,000 sh
- John Donofrio Jr. - DirectorGrant or award10,000 sh
About AYTU BIOPHARMA, INC (AYTU)
Aytu BioPharma Inc is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients. It has single operating segment. Its product portfolio includes EXXUA, ADHD Portfolio, Pediatric Portfolio, and Other. Majority of revenue comes from ADHD Portfolio. It has presence in United States.
- DENVER, CO
- 76
- 2008
- XNAS
AYTU Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 8 | 130,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AYTU insider transactions (Form 4)
2925 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joshua R. Disbrow - Officer | Grant or award | Common Stock | 30,000 footnote F1 | $0.00 | - | |
| ||||||
| Greg Pyszczymuka - Officer | Grant or award | Common Stock | 20,000 footnote F1 | $0.00 | - | |
| ||||||
| Jarrett Disbrow - Officer | Grant or award | Common Stock | 15,000 footnote F1 | $0.00 | - | |
| ||||||
| Ryan J. Selhorn - Officer | Grant or award | Common Stock | 25,000 footnote F1 | $0.00 | - | |
| ||||||
| Vivian H. Liu - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Abhinav Jain - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Carl Dockery - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| John Donofrio Jr. - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Greg Pyszczymuka - Officer | Grant or award | Common Stock | 12,500 footnote F1 | $0.00 | - | |
| ||||||
| Jarrett Disbrow - Officer | Grant or award | Common Stock | 19,606 footnote F1 | $0.00 | - | |
| Jarrett Disbrow - Officer | Grant or award | Common Stock | 12,500 footnote F2 | $0.00 | - | |
| ||||||
| Ryan J. Selhorn - Officer | Grant or award | Common Stock | 16,243 footnote F1 | $0.00 | - | |
| Ryan J. Selhorn - Officer | Grant or award | Common Stock | 17,500 footnote F2 | $0.00 | - | |
| ||||||
| Joshua R. Disbrow - Officer | Grant or award | Common Stock | 31,446 footnote F1 | $0.00 | - | |
| Joshua R. Disbrow - Officer | Grant or award | Common Stock | 22,500 footnote F2 | $0.00 | - | |
| ||||||
| Abhinav Jain - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Carl Dockery - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| John Donofrio Jr. - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Vivian H. Liu - Director | Grant or award | Common Stock | 10,000 footnote F1 | $0.00 | - | |
| ||||||
| Ryan J. Selhorn - Officer | Grant or award | Common Shares | 14,000 | $0.00 | - | |
| Carl Dockery | Grant or award | Common Shares | 1,500 | $0.00 | - | |
| John Donofrio Jr. | Grant or award | Common Shares | 1,500 | $0.00 | - | |
| Abhinav Jain | Grant or award | Common Shares | 1,500 | $0.00 | - | |
| Joshua R. Disbrow - Officer | Grant or award | Employee Stock Option (Right to Buy) | 38,000 | $0.00 | - | |
| Jarrett Disbrow - Officer | Grant or award | Employee Stock Option (Right to Buy) | 7,000 | $0.00 | - | |
| Greg Pyszczymuka - Officer | Grant or award | Employee Stock Option (Right to Buy) | 7,000 | $0.00 | - | |
| Vivian H. Liu | Grant or award | Common Shares | 1,500 | $0.00 | - | |
| Greg Pyszczymuka - Officer | Option exercise | Common Shares | 209 | - | - | |
| Greg Pyszczymuka - Officer | Option exercise | Restricted Stock Units | 209 | $0.00 | - | |
Item 2.02, 9.01
Item 1.02
Item 2.02, 9.01
Item 1.01, 2.02, 3.02, 3.03, 9.01
AYTU insider trading FAQ
What is the latest insider trade for AYTU?
AYTU BIOPHARMA, INC (AYTU) had 8 insider filings in the last 90 days, with the most recent on 2026-07-30. The full record for AYTU runs to 25 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AYTU stock?
No insider purchases of AYTU were filed in the last 90 days.
How many insiders are selling AYTU stock?
No insider sales of AYTU were filed in the last 90 days.
Where can I see AYTU SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AYTU Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joshua R. Disbrow view on EDGAR
- - Greg Pyszczymuka view on EDGAR
- - Jarrett Disbrow view on EDGAR
- - Ryan J. Selhorn view on EDGAR
- - Vivian H. Liu view on EDGAR
- - Abhinav Jain view on EDGAR
- - Carl Dockery view on EDGAR
- - John Donofrio Jr. view on EDGAR
- - Greg Pyszczymuka view on EDGAR
- - Jarrett Disbrow view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AYTU's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AYTU with a 7-day demo
- AYTU on your watchlist
- Every AYTU Form 4 filing on record
- Up to 3 months of AYTU price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.